Site Map
Pages
- CDRC Accomplishments
- C-Path Collaborators
- PAN-TB
- CPTA's Requests to House and Senate
- Ship-MD
- AD-CTS Tool Request - Failed
- AD-CTS Tool Request Success
- AD CTS Tool Request Terms
- AD CTS Tool Request
- Additional RDCA-DAP Resources
- PRO Consortium Annual Workshop Archives
- Patient-Centered Evidence Consortium (PCEC) Publications, White Papers and Resources
- CDRC and CURE ID FAQs
- Shop
- CDRC Additional Resources
- CDRC Annual Meeting Resources
- TRxA FAQs
- Subscribe to C-Path News
- CPTA: How We Do It
- Neonatal Drug Development Education Modules
- INC Tools, Resources, and FAQs
- Prior Efforts
- Collaboration, Community, and Culture
- Evidentiary Considerations
- Contact Form Submitted
- I-ACT Webinars and Publications
- FA-ICD: Regulatory-Grade Evidence for a Rare Disease References
- Translations & Licensing Management: Acknowledgments
- Frequently Asked Questions about Translations & Licensing Management
- About Translations & Licensing Management
- Translations & Licensing Management (TLM)
- COA Annual Meeting Resources
- BmDR Newsletters
- New Approach Methodologies Developer Coalition (NAMs-DC)
- eCOA FAQs
- Patient-Centered Evidence Consortium (PCEC) FAQs
- C-Path's Nonprofit Partners
- Sarcoma Patient Resources
- Critical Path for Parkinson's Regulatory Successes and Community Impact
- Alzheimer's Consortium Regulatory Successes, Letters of Support and Timeline
- New-Onset Clinical Trial Simulation Tool
- eCOA Newsletters and Webinars
- C-Path Europe's Gender and Equity Plan
- Request for Proposals
- Secure Donation
- Support C-Path's Mission
- My account
- Checkout
- Cart
- Home
- What We Do
- Program List
- Core Competencies
- Impact
- Story List
- Media
- Resources
- Training
- Apply for the Early Motor Parkinson's DAT Clinical Trial Enrichment Tool
- Early Motor Parkinson's DAT Clinical Trial Enrichment Tool Terms and Conditions
- Alzheimer's Disease (AD) Clinical Trial Simulation Tool Terms and Conditions
- Hippocampal Neuroimaging-Informed Amnestic MCI Clinical Trial Simulator
- Multiple Sclerosis Outcome Assessments Consortium (MSOAC) Placebo Database FAQ
- Tools & Platforms
- CODR Databases
- Alzheimer's Disease Clinical Trial Simulation Tool
- Alzheimer's Pre-dementia Clinical Trial Enrichment Tool
- DMD Clinical Trial Simulation Tool
- Islet Antibody Clinical Trial Enrichment Tool
- Integrated Parkinson's Database
- Critical Path For Alzheimer’s Disease (CPAD) Database
- Early Motor Parkinson's DAT Clinical Trial Enrichment Tool
- PRO Consortium Measures and Licensing
- MSOAC
- RDCA-DAP
- D-RSC Database
- D-RSC Database Copy
- FA-ICD Database
- MSOAC Database
- PK-DOC Database
- TB APEX
- TB PACTS
- 20 Years of Impact
- About
- FDA Acknowledgement
- Data Contribution Agreement GDPR
- Privacy Policy
- Policies
- Terms
- Contact Us
- PDF Convertor
Programs
- New Approach Methodologies Developer Coalition
- One to Millions
- Critical Path for Alpha-1 Antitrypsin Deficiency
- Critical Path for Lysosomal Diseases Pre-Consortium
- C-Path Europe
- Type 1 Diabetes Consortium
- Critical Path for Rare Neurodegenerative Diseases
- Quantitative Medicine Program
- Critical Path to Therapeutics for the Ataxias
- Duchenne Regulatory Science Consortium
- Translational Therapeutics Accelerator
- Regulatory Science Program
- Huntington’s Disease Regulatory Science Consortium
- Polycystic Kidney Disease Outcomes Consortium
- Rare Disease Clinical Outcome Assessment Consortium
- Predictive Safety Testing Consortium
- Rare Disease Cures Accelerator-Data and Analytics Platform
- Patient-Centered Evidence Consortium
- Electronic Clinical Outcome Assessment Consortium
- International Neonatal Consortium
- Freidreich's Ataxia Integrated Clinical Database (FA-ICD)
- Data Collaboration Center
- Critical Path for Parkinson's
- Critical Path for Alzheimer's Disease
- Biomarker Data Repository
Category
- Core Competencies
- Neuroscience
- Rare and Orphan Diseases
- Pediatrics
- Innovation in Translational Science and Biomarkers
- Clinical Outcome Assessment
Tags
Categories
- Annual Meetings
- Blog
- Events
- News
- Newsletters
- Podcasts
- Posters
- Presentations
- Press Releases
- Publications
- Uncategorized
- Videos
- Webinars
- Workshops
Consortia
- Biomarker Data Repository
- Critical Path for Alpha-1 Antitrypsin Deficiency
- Critical Path for Alzheimer's Disease
- Critical Path for Parkinson’s
- Critical Path for Rare Neurodegenerative Diseases
- Critical Path to TB Drug Regimens
- Critical Path to Therapeutics for the Ataxias
- CURE Drug Repurposing Collaboratory
- Duchenne Regulatory Science Consortium
- Huntington’s Disease Regulatory Science Consortium
- International Neonatal Consortium
- Patient-Reported Outcome Consortium
- Polycystic Kidney Disease Outcomes Consortium
- Quantitative Medicine Program
- Rare Disease Cures Accelerator-Data and Analytics Platform
- Testing connection
- Translational Therapeutics Accelerator
- Transplant Therapeutics Consortium
- Type 1 Diabetes Consortium
Products
WC Donation
Campaign Categories
COA Resources
- Stakeholders and Responsibilities
- eCOA Licensing Roadmap
- eCOA Translation Implementation and Standardization Information Tool
- COA Translation and Electronic Migration Communications Among Stakeholders | Challenges and Recommended Approaches
- Impact of Translation Availability on the Patient Voice in Clinical Trials: Commentary
- Clinical Outcome Assessment Translation Requirements
- Project Scoping and RACI
COA Resource Types
- Commentary / Reference Article
- Interactive Reference Guidelines
- Process Roadmap
- Reference Guidelines
- Requirements Document
- Template
- Workflow Guide
